Pricing Log in Create free account

CAMP4 Therapeutics Corporation (CAMP) vs Lineage Cell Therapeutics, Inc. (LCTX)

CAMP4 Therapeutics Corporation and Lineage Cell Therapeutics, Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Lineage Cell Therapeutics, Inc. are of similar size ($258.0M and $254.8M). CAMP4 Therapeutics Corporation grew revenue faster over the last twelve months: 52.0% against 19.9%. Lineage Cell Therapeutics, Inc. has the higher net margin (−246.6% vs −2,276.3%) and the lower return on invested capital (−186.8% vs 0.00%). Across the 17 metrics below, Lineage Cell Therapeutics, Inc. leads on 9 and CAMP4 Therapeutics Corporation on 8.

Valuation

Metric CAMP LCTX Biotechnology median
P/E n/m n/m 10.60
P/S 60.25 19.45 9.40
P/B 2.99 4.26 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 36.71 15.57 9.02
Earnings yield (49.68%) (14.10%) (32.88%)
Free cash flow yield (8.23%) (9.58%) (23.13%)

Profitability

Metric CAMP LCTX Biotechnology median
Gross margin 100.00% 99.46% 68.51%
Operating margin (1,001.05%) (205.23%) 0.00%
Net margin (2,276.33%) (246.58%) 0.00%
Free cash flow margin (495.71%) (186.43%) 0.00%
Return on equity (146.12%) (60.35%) (51.96%)
Return on assets (109.89%) (32.75%) (46.06%)
Return on invested capital 0.00% (186.79%) 0.00%

Growth

Metric CAMP LCTX Biotechnology median
Revenue growth (TTM) 52.00% 19.87% 6.76%
EPS growth (last fiscal year) 76.00% (211.11%) 29.88%
Revenue growth, 5-year CAGR — 51.46% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CAMP LCTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.42 6.61 4.97
Net debt to EBITDA 2.18 2.64 1.01

Dividend

Metric CAMP LCTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CAMP LCTX Biotechnology median
Market cap 254.78m 257.97m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack